Unfavourable prognostic significance of S100P expression in ovarian cancers
- 31 May 2007
- journal article
- Published by Wiley in Histopathology
- Vol. 51 (1) , 125-127
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancersCancer Letters, 2006
- Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrationsInternational Journal of Cancer, 2005
- S100P is selectively upregulated in tumor cell lines challenged with DNA cross-linking agentsLeukemia Research, 2005
- S100P Stimulates Cell Proliferation and Survival via Receptor for Activated Glycation End Products (RAGE)Journal of Biological Chemistry, 2004
- Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell linesAnti-Cancer Drugs, 1998